Formycon AG/€FYB
1D1W1M3M6MYTD1Y5YMAX
Capital at risk
About Formycon AG
Formycon AG is a biotechnology company based in Planegg, Germany, specializing in the development of biosimilar products. The company focuses primarily on creating biosimilar versions of top-selling biopharmaceuticals, addressing fields such as ophthalmology and immunology. Known for its significant expertise in protein and biopharmaceutical development, Formycon leverages its proprietary technical platform to advance its biosimilar pipeline. The company's strategic positioning includes partnerships with other pharmaceutical firms to co-develop and commercialize its biosimilar candidates. Formycon's competitive strength lies in its robust development capabilities and focus on high-growth therapeutic areas.
- Ticker
- €FYB
- Sector
- Health
- Primary listing
- XETRA
- Employees
- 196
- Headquarters
- Planegg, Germany
- Website
- www.formycon.com
Formycon AG Metrics
BasicAdvanced
€264M
-
-€1.42
0.72
-
Price and volume
Market cap
€264M
Beta
0.72
52-week high
€26.85
52-week low
€13.90
Average daily volume
8.3K
Financial strength
Current ratio
2.039
Quick ratio
1.42
Long term debt to equity
0.019
Total debt to equity
0.022
Profitability
EBITDA (TTM)
9.407
Gross margin (TTM)
22.81%
Net profit margin (TTM)
-41.04%
Operating margin (TTM)
-24.25%
Effective tax rate (TTM)
51.36%
Revenue per employee (TTM)
€310,000
Management effectiveness
Return on assets (TTM)
-1.27%
Return on equity (TTM)
-6.33%
Valuation
Price to revenue (TTM)
4.25
Price to book
0.69
Price to tangible book (TTM)
-9.57
Price to free cash flow (TTM)
-6.325
Free cash flow yield (TTM)
-15.81%
Free cash flow per share (TTM)
-2.329
Growth
Revenue change (TTM)
18.28%
Earnings per share change (TTM)
-85.19%
3-year revenue growth (CAGR)
-3.73%
10-year revenue growth (CAGR)
14.46%
3-year earnings per share growth (CAGR)
-19.54%
10-year earnings per share growth (CAGR)
19.72%
What the Analysts think about Formycon AG
Analyst ratings (Buy, Hold, Sell) for Formycon AG stock.
Analyst projections of the future price of Formycon AG stock.
Formycon AG Financial Performance
Revenues and expenses
Formycon AG Earnings Performance
Company profitability
Upcoming events
No upcoming events
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe and Deutsche Börse.